Previous studies have stated that blockage of NF-κB activity increases the efficiency of chemotherapy by cisplatin in ovarian cancer models [11] and suppresses ovarian cancer cell metastasis [12]. This evidence concerns the gene NFKB1 and ovarian carcinoma.